Articles related to PRODUCT RECALL

The FDA’s Class II designation indicates that exposure or usage of ‘a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.’

The recall encompasses three dosages for prazosin hydrochloride capsules: 181K+ bottles of 1-milligram doses, 291K+ bottles of 2-milligram doses, and 107K+ bottles of 5-milligram doses, all distributed nationwide.

The FDA says on its website that it has been investigating drugs for nitrosamines in some types of medications, noting they’re common in water and foods. But the agency noted that such impurities have been linked to an increase in cancer in individuals who are exposed to elevated levels and over long periods of time.

If your patients have the recalled deodorant, they should stop using it. Advise to throw it away or return it to the store.

The recall was initiated because the medication content of the recalled pills is ‘below the approved specification’.

“The FDA said the reason for the recall is that the ‘product failed to meet dissolution acceptance criteria in the stability studies at the 6th month.'”